NEW CASTLE, Del.--(BUSINESS WIRE)--In honor of August being International Autoinflammatory Awareness Month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for enhanced education and awareness of these rare diseases and conditions.
Autoinflammatory diseases refer to problems with the innate immune system’s reactions. Immune cells target the body’s own healthy tissues by mistake, signaling the body to attack them. This can cause intense episodes of inflammation that result in such symptoms as fever, rash, or joint swelling. These diseases also carry the risk of amyloidosis, a potentially fatal buildup of a blood protein in vital organs. Autoinflammatory diseases are typically caused by changes in certain genes. This causes problems with proteins that are important in specific body functions.
BioTek reMEDys is urging its colleagues, patients, and the population at large to become more aware and help drive education regarding these conditions.
Two examples of such diseases include PAPA (Pyogenic Arthritis, Pyoderma gangrenosum and Acne), an autoinflammatory disease causing painful flares of arthritis, poorly healing skin ulcers, and/or severe cystic acne; and CRMO (Chronic Recurrent Multifocal Osteomyelitis), an autoinflammatory disease causing pain and damage in bones throughout the body. BioTek reMEDys is well-positioned to help patients with these conditions.
“Because many autoimmune conditions are statistically rare, they can often be misdiagnosed and we hope to help shine a light on the importance of education about these conditions,” said Chaitanya Gadde, CEO and founder of BioTek reMEDys. “Treatments for autoinflammatory diseases are typically very effective and can involve medications that reduce inflammation or suppress the immune system to alleviate symptoms. The diagnosis and treatment of autoimmune disorders can be very complex, requiring knowledgeable and dedicated staff to help provide guidance and counseling to patients during a challenging time in their lives.”
By servicing very specific disease states such as autoinflammatory conditions, BioTek reMEDys’ expert team can maintain its focus on patient care – making sure that dosages and treatments are appropriate.
Additional information and news about autoinflammatory diseases can be found at the Autoinflammatory Alliance; NORD (National Organization for Rare Disorders); CRMO Foundation; and the International Society of Systemic Auto-inflammatory Diseases (ISSAID) website, issaid.org.
BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases. Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost. The company bridges the gap between managed care, physicians and patients by facilitating the authorization, procurement and administration of specialty medications and infusions. BioTek reMEDys provides high-touch therapies, biologics and pharmaceuticals to support treatment for patients with rare diseases and chronic conditions, ensuring the highest quality of care. For information visit www.biotekrx.com.